274 results on '"O'Shea, Anne"'
Search Results
2. Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study)
3. Contributors
4. Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
5. Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial
6. Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention
7. Analysis of Concomitant and Isolated Venous Injury in Military Lower Extremity Trauma
8. Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival
9. Thymic adenocarcinoma presenting as an incidental mediastinal mass
10. Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes
11. The roles of repetitive negative thinking and perfectionism in explaining the relationship between sleep onset difficulties and depressed mood in adolescents
12. The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy
13. Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer
14. ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma
15. Facilitation Skills for Library Professionals
16. Tumor Lysate Particle Only Vaccine (TLPO) vs. Tumor Lysate Particle-Loaded, Dendritic Cell Vaccine (TLPLDC) to Prevent Recurrence in Resected Stage III/IV Melanoma Patients: Results of a Phase I/IIa Trial
17. Cognitive-Behavioral Model
18. The role of self‐reliance and denial in the help‐seeking process for eating disorders among university students
19. The unmet treatment need for eating disorders: What has changed in more than 10 years? An updated systematic review and meta-analysis
20. Implementation of evidence-based group interventions in a community-based mental health service for self-harming and suicidal youth
21. The role of self‐reliance and denial in the help‐seeking process for eating disorders among university students.
22. Perfectionism and Eating Disorders
23. Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis
24. Implementation of evidence-based group interventions in a community-based mental health service for self-harming and suicidal youth.
25. Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters.
26. Supplementary Table S4 from Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ
27. Data from Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ
28. Supplementary Fig. S1 from Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ
29. Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ
30. Supplemental Table 1 from Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression
31. Supplemental File 2 from Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression
32. Supplemental Table 2 from Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression
33. Supplemental File 1 from Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression
34. Supplemental Table 3 from Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression
35. Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials
36. The 4th Schizophrenia International Research Society Conference, 5 –9 April 2014, Florence, Italy: A summary of topics and trends
37. Use of Leishmania major parasites expressing a recombinant Trypanosoma cruzi antigen as live vaccines against Chagas disease
38. The 3rd Schizophrenia International Research Society Conference, 14–18 April 2012, Florence, Italy: Summaries of oral sessions
39. Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial
40. Cognitive-Behavioral Model
41. Perfectionism and Eating Disorders
42. The 2nd Schizophrenia International Research Society Conference, 10–14 April 2010, Florence, Italy: Summaries of oral sessions
43. Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer
44. 542 Randomized trial of tumor lysate particle only vaccine vs. tumor lysate particle-loaded, dendritic cell vaccine to prevent recurrence of resected stage III/IV melanoma: 36-month analysis
45. An Autologous Tumor Lysate Dendritic Cell Vaccine Is Most Effective in Recurrent, Advanced-Stage Melanoma in a Randomized Controlled Trial
46. Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma
47. Germline BRCA1 mutations predispose to pancreatic adenocarcinoma
48. Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma
49. Thymic adenocarcinoma presenting as an incidental mediastinal mass.
50. Pathology Features in Bethesda Guidelines Predict Colorectal Cancer Microsatellite Instability: A Population-Based Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.